scispace - formally typeset
JournalISSN: 1474-1776

Nature Reviews Drug Discovery

About: Nature Reviews Drug Discovery is an academic journal. The journal publishes majorly in the area(s): Drug development & Cancer. It has an ISSN identifier of 1474-1776. Over the lifetime, 4252 publication(s) have been published receiving 479341 citation(s). The journal is also known as: Nature Reviews. Drug Discovery & Nat Rev Drug Discov.

...read more

Topics: Drug development, Cancer, Drug discovery ...read more
Papers
  More

Journal ArticleDOI: 10.1038/NRD1632
Vladimir P. Torchilin1Institutions (1)
Abstract: Liposomes — microscopic phospholipid bubbles with a bilayered membrane structure — have received a lot of attention during the past 30 years as pharmaceutical carriers of great potential. More recently, many new developments have been seen in the area of liposomal drugs — from clinically approved products to new experimental applications, with gene delivery and cancer therapy still being the principal areas of interest. For further successful development of this field, promising trends must be identified and exploited, albeit with a clear understanding of the limitations of these approaches.

...read more

4,185 Citations


Journal ArticleDOI: 10.1038/NRD2614
Abstract: Nanoparticles — particles in the size range 1–100 nm — are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.

...read more

3,696 Citations


Journal ArticleDOI: 10.1038/NRD2803
Abstract: Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, and recent studies suggest that this biochemical property of cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumours frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacological ROS insults. However, the upregulation of antioxidant capacity in adaptation to intrinsic oxidative stress in cancer cells can confer drug resistance. Abrogation of such drug-resistant mechanisms by redox modulation could have significant therapeutic implications. We argue that modulating the unique redox regulatory mechanisms of cancer cells might be an effective strategy to eliminate these cells.

...read more

Topics: Cancer cell (58%), Oxidative stress (54%)

3,691 Citations


Journal ArticleDOI: 10.1038/NRD1470
Ismail Kola1, John Landis2Institutions (2)
Abstract: The pharmaceutical industry faces considerable challenges, both politically and fiscally. Politically, governments around the world are trying to contain costs and, as health care budgets constitute a very significant part of governmental spending, these costs are the subject of intense scrutiny. In the United States, drug costs are also the subject of intense political discourse. This article deals with the fiscal pressures that face the industry from the perspective of R&D. What impinges on productivity? How can we improve current reduced R&D productivity?

...read more

Topics: Productivity (52%)

3,500 Citations


Journal ArticleDOI: 10.1038/NRD2060
Joseph A. Baur1, David A. Sinclair1Institutions (1)
Abstract: Resveratrol, a constituent of red wine, has long been suspected to have cardioprotective effects. Interest in this compound has been renewed in recent years, first from its identification as a chemopreventive agent for skin cancer, and subsequently from reports that it activates sirtuin deacetylases and extends the lifespans of lower organisms. Despite scepticism concerning its bioavailability, a growing body of in vivo evidence indicates that resveratrol has protective effects in rodent models of stress and disease. Here, we provide a comprehensive and critical review of the in vivo data on resveratrol, and consider its potential as a therapeutic for humans.

...read more

Topics: Resveratrol (58%), Sirtuin (52%)

3,254 Citations


Performance
Metrics
No. of papers from the Journal in previous years
YearPapers
2021206
2020216
2019210
2018217
2017251
2016257

Top Attributes

Show by:

Journal's top 5 most impactful authors

Sarah Crunkhorn

485 papers, 718 citations

Asher Mullard

315 papers, 4.3K citations

Charlotte Harrison

224 papers, 491 citations

Peter Kirkpatrick

214 papers, 516 citations

Alexandra Flemming

122 papers, 342 citations

Network Information
Related Journals (5)
Drug Discovery Today

5K papers, 227.1K citations

85% related
Drug Discovery Today: Technologies

615 papers, 16.7K citations

84% related
Current Opinion in Drug Discovery & Development

871 papers, 26.5K citations

82% related
Nature Reviews Immunology

3.7K papers, 674.6K citations

82% related
Annual Review of Pharmacology and Toxicology

1.1K papers, 237.3K citations

81% related